- Home
- SKK vs ADXN Comparison
SKK vs ADXN Comparison
Compare SKK & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKK
- ADXN
- Stock Information
- Founded
- SKK 2013
- ADXN 2002
- Country
- SKK Singapore
- ADXN Switzerland
- Employees
- SKK N/A
- ADXN N/A
- Industry
- SKK
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- SKK
- ADXN Health Care
- Exchange
- SKK NYSE
- ADXN Nasdaq
- Market Cap
- SKK 12.0M
- ADXN 10.1M
- IPO Year
- SKK 2024
- ADXN N/A
- Fundamental
- Price
- SKK $0.65
- ADXN $7.54
- Analyst Decision
- SKK
- ADXN Strong Buy
- Analyst Count
- SKK 0
- ADXN 1
- Target Price
- SKK N/A
- ADXN $30.00
- AVG Volume (30 Days)
- SKK 60.3K
- ADXN 14.4K
- Earning Date
- SKK 02-14-2025
- ADXN 08-11-2025
- Dividend Yield
- SKK N/A
- ADXN N/A
- EPS Growth
- SKK 99.13
- ADXN N/A
- EPS
- SKK 0.03
- ADXN 0.10
- Revenue
- SKK $11,301,000.00
- ADXN $278,508.00
- Revenue This Year
- SKK N/A
- ADXN $86.57
- Revenue Next Year
- SKK N/A
- ADXN N/A
- P/E Ratio
- SKK $21.86
- ADXN $0.75
- Revenue Growth
- SKK 15.80
- ADXN N/A
- 52 Week Low
- SKK $0.53
- ADXN $6.51
- 52 Week High
- SKK $11.45
- ADXN $13.27
- Technical
- Relative Strength Index (RSI)
- SKK N/A
- ADXN 33.59
- Support Level
- SKK N/A
- ADXN $8.83
- Resistance Level
- SKK N/A
- ADXN $9.15
- Average True Range (ATR)
- SKK 0.00
- ADXN 0.47
- MACD
- SKK 0.00
- ADXN -0.16
- Stochastic Oscillator
- SKK 0.00
- ADXN 0.00
About SKK SKK HOLDINGS LIMITED
SKK Holdings Ltd is a civil engineering service provider that specializes in subsurface utility works in Singapore. It construct and maintain various public works and infrastructure projects that serve the society and the environment. Its projects are the subsurface work related to projects undertaken by the Public Utilities Board (PUB) and Singapore Telecommunications Limited. The nature of these projects is related to repairing of pumping mains, sewer maintenance and pipe cable laying.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.